DBDeus Bazira

Deus Bazira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Deus Bazira has a total of 67 co-authors. Here are the top co-authors by number of shared publications:

  • Bryan Shaw

    Affiliation Center for Global Health Practice and Impact, Georgetown University, Washington, DC, United States of America

    3 shared publications
  • Arnold Mafukidze

    Affiliation Center for Global Health Practice and Impact, Georgetown University, Mbabane, Eswatini

    2 shared publications
  • Babatunji Oni

    Affiliation Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America

    2 shared publications
  • Bryan Shaw

    Center for Global Health Practice and Impact (CGHPI), Georgetown University Medical Center, United States

    2 shared publications
  • Christopher Loffredo

    Affiliation Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, United States of America

    2 shared publications
  • Cory Freivald

    Affiliation Department of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America

    2 shared publications

Latest Publications

  • Open Access

    Predictors of smart pillboxes adoption intent among people living with HIV in Cameroon: a cross-sectional study

    by Armel F. Setubi, Bryan Shaw, Katherine Robsky, Ignace Gashongore, Michael Ochieng Otieno, Vinie Kouamou, Xavier Gabriel Fopokam, Rhonda BeLue, Joy Musa Shallangwa, Deus Bazira, et al.

    Background: Maintaining high levels of medication adherence is essential for the success of antiretroviral therapy (ART), yet non-adherence remains a persistent challenge in resource-limited settings. Smart Pillboxes (SPBs) offer a promising digital solution by providing real-time adherence monitoring and clinical decision support. However, the successful implementation of these tools among people living with HIV (PLHIV) depends on understanding user-level barriers. This study examines the sociodemographic, behavioral, and infrastructural factors that influence the willingness to adopt SPBs among people living with HIV in Cameroon. Methods: This cross-sectional study involved 153 PLHIV recruited from clinical sites in the Center Region of Cameroon. The Diffusion of Innovations (DOI) framework informed the conceptual categorization. Due to convergence issues with log-binomial models, statistical analyses utilized multivariable modified Poisson regressions with robust standard errors to identify predictors of adoption intent. Global model significance was assessed via the Wald Chi-square test. A bootstrap procedure was applied to validate the stability of identified predictors. Results: At the outset, 60.8% of participants self-classified as adopters. Females were the majority (53%), and over half of the participants were single (55.6%). The final multivariable model demonstrated high statistical significance (Wald $$\:{\chi\:}^{2}$$ = 29.5, p = 0.0019). Higher educational attainment (MA; aRR = 1.64, p = 0.004) and frequent medication forgetfulness (aRR = 1.35, p = 0.026) were identified as robust facilitators of adoption willingness. Adoption intent was significantly attenuated by the use of phone reminders (aRR = 0.77, p = 0.049) and unemployment (aRR = 0.64, p = 0.049). Conclusion: Adoption intent of SPBs is driven by a synergy of socioeconomic status and felt behavioral needs. While infrastructure is a necessary baseline, educational attainment and perceived utility are the primary determinants of adoption intent in this urban population.

  • Open Access

    A Retrospective Cohort Analysis Investigating Determinants and Rates of Retention among Children and Adolescents Receiving Antiretroviral Therapy in Center and East Regions of Cameroon

    by Bryan Shaw, Nkenkeu Kieuvo Ignace, Mbogwe Ndimumeh, Lauren Mathae, Ryan Neil, Chibuike Mark Ogbuabo, Julienne Mesumbe, Ignace Gashongore, Deus Bazira

    Background: Children and adolescents (0 – 15 years) living with HIV (ACLHIV) in low-resource settings face individual, household, and systemic challenges to engagement and retention in HIV care and antiretroviral treatment (ART) adherence. As a result, ACLHIV register poorer care and treatment outcomes. We describe care retention outcomes and factors that influence them among ACLHIV enrolled in ART in Cameroon. Methods: We explored trends in two-year follow-up and sociodemographic and clinical factors associated with retention in care among ACLHIV living in the Center and East Regions. We retrospectively analyzed anonymized medical records ( n = 1,319) from a cohort of all ACLHIV initiating ART for a three-year period between October 1, 2019, to September 30, 2022. Data were obtained from electronic medical records from 66 HIV treatment sites. Trends in retention in care among ACLHIV on ART were described using Kaplan-Meier survival estimates. Cox proportional analysis was performed to identify factors associated with retention in care. Results: Retention in care among ACLHIV in both regions at months 6, 12, 18, and 24 was 86.2%, 82.6%, 79.8%, and 77.2%, respectively. After 24 months, retention was higher in the Center Region (83.1%) compared to the East Region (71.5%). In adjusted regression models, female ACLHIV were more likely to be retained in care in the Center Region but less likely in the East Region compared to boys after 24 months. Clinical treatment factors, such as current use of a dolutegravir and receipt of ART through differentiated service delivery models, were associated with a considerably reduced risk of loss to follow-up. Unexpectedly, we found that very young children (<5 years) were less likely to be retained in care than older adolescents (5-15 years), which could be partially explained by local context of care. Conclusion: This study suggests that Cameroon is lagging behind targets for HIV retention in care for ACLHIV. More effective and targeted clinical and social behavioral interventions are needed to address barriers to long term engagement in care by ACLHIV. Targeted research studies and improved data-driven, process monitoring is needed to determine other underlying factors that lead to sub-optimal care retention outcomes among this sub-population.

  • Open Access

    Opportunities and challenges in access to healthcare for international migrants with work-related diseases and injuries in Gulf Cooperation Council countries: A systematic literature review protocol

    by Weijun Yu, Aleena Dawer, Jeanetta Floyd, Nicole Saad, Jiaqin Wu, Katherine O. Robsky, Oliver Johnson, Yulia Hutsul, Dylan Ratnarajah, Bryan Shaw, et al.

    Introduction: International labor migrants form a significant part of the global workforce, particularly in the Gulf Cooperation Council (GCC) countries, which host around 11% of the world’s migrant workforce. This high concentration presents unique challenges in healthcare access and delivery. This systematic review aims to evaluate whether international labor migrants in GCC countries have effective access to healthcare for work-related diseases and injuries and to propose evidence-based recommendations for policy and healthcare interventions. Methods: We will include studies from 2013 to 2023 published in peer-reviewed journals in English or Arabic (with English abstracts) available on PubMed, Embase and CINAHL. Search strategies are developed using MeSH terms and key terms related to our study population (international labor immigrants), context (the GCC countries), and exposure (migrant status; work-related diseases and injuries). The screening process involves two stages: initial review of titles/abstracts and full-text review. Studies meeting eligibility criteria and focusing on our primary outcome (access to healthcare) will be included. Data extraction will cover study characteristics, population demographics, described exposures, outcomes measured, and key findings. Given the expected heterogeneity, narrative synthesis will be primarily used, with meta-analysis as an option. Discussion: By considering both migrant workers and expatriate professionals, we provide a culturally tailored perspective. Methodological rigor is ensured through the gold standard screening process, where at least two reviewers independently screen the literature at each stage, with a senior reviewer resolving discrepancies. We will identify barriers, facilitators, and inform targeted interventions for policymakers. Our findings will support evidence-based strategies to improve healthcare access for international labor migrants in the GCC countries. Systematic review registration: This systematic review protocol was registered on the international registry PROSPERO (CRD42024532851) on April 21, 2024.


  • Open Access

    Factors associated with COVID-19 vaccine hesitancy and uptake among populations in the West department of Haiti

    by Martine Etienne-Mesubi, Babatunji Oni, Nancy Rachel Labbe-Coq, Marie Colette Alcide-Jean-Pierre, Delva Lamarre, Darwin Dorestan, Marie-Ange Bien-Aime, Venice Dorce, Cory Freivald, Cowan Angell, et al.

    Introduction: The COVID-19 pandemic in Haiti led to increased challenges for a population concurrently dealing with natural and social disasters, poor quality health care, lack of clean running water, and inadequate housing. In 2022, the population of Haiti was 11.4 million. While half a million vaccines for COVID-19 were donated by the United States to the government of Haiti, less than 5% of the population agreed to be vaccinated. This resulted in thousands of unused doses that were diverted to other countries. The purpose of this study was to evaluate population characteristics related to vaccine uptake in order to inform future interventions to improve COVID-19 vaccine uptake as well as inform strategies to safeguard against future global health security threats. Methods: This was a mixed-methods, cross-sectional study conducted in the West Department of Haiti within peri-urban communes. Participants consisted of adults in this setting responding to a survey from June 15 to July 18, 2022. The survey assessed demographic information, household characteristics, religious beliefs, past vaccine use, and current COVID-19 vaccine status. Multivariate regression modeling was conducted to assess predictors of vaccine hesitancy. Qualitative focus group discussion participants were recruited and focus group discussions were conducted between August-September 2022 among community groups, religious leaders and health professionals to provide additional, community-level context on perceptions of the COVID-19 pandemic and vaccines. Results: A total of 1,923 respondents completed the survey; of which a majority were male (52.7%), between the age of 18–35 (58.5%), had a medical visit within the last year (63.0%) and received the COVID-19 vaccine (46.1%). Compared to those who had been COVID-19 vaccinated, participants who had not been vaccinated were more likely to be male (57.7% vs 46.8%, p < .0001), have completed secondary education (30.5% vs 16.6%, p < .001), unemployed (20.3% vs 7.3%, p < .0001) and had a medical visit 3 or more years ago (30.2% vs 11.2%, p < .0001). Unvaccinated COVID-19 participants were also more likely to have never received any other vaccine (36.1% vs22.5%, p < .0001), have a religious leader speak out against the vaccine (20.0% vs 13.1%, p < .0001), not believe in the effectiveness of the vaccine (51.2% vs 9.1%, p < .0001) and did not trust the healthcare worker administering the vaccine (35.2% vs 3.8%, p<0.0001). Conclusion: These results show that targeted interventions to religious leaders and health care workers on how to engage with the community and share clearer messages around the COVID-19 vaccination may result in increased vaccine uptake. Results also shed light on how activities surrounding vaccinations can be tailored to meet client needs addressing the misinformation encountered to achieve greater health impact thereby safeguarding the population against future global health security threats.


  • Open Access

    Cervical cancer screening outcomes for HIV-positive women in the Lubombo and Manzini regions of Eswatini—Prevalence and predictors of a positive visual inspection with acetic acid (VIA) screen

    by Rufaro Mapaona, Victor Williams, Normusa Musarapasi, Sharon Kibwana, Thokozani Maseko, Rhinos Chekenyere, Sidumo Gumbo, Phetsile Mdluli, Hugben Byarugaba, Dileepa Galagedera, et al.

    This study aimed to describe the prevalence and predictors of a positive VIA (visual inspection with acetic acid) cervical cancer screening test in women living with human immunodeficiency virus (HIV). We retrospectively analysed data from women aged ≥15 who accessed VIA screening from health facilities in the Lubombo and Manzini regions of Eswatini. Sociodemographic and clinical data from October 2020 to June 2023 were extracted from the client management information system (CMIS). VIA screening outcome was categorised into negative, positive, or suspicious. A logistic regression model estimated the adjusted odds ratio (AOR) of the predictors of a positive VIA screen at p<0.05 with 95% confidence intervals. Of 23,657 participants, 60.8% (n = 14,397) were from the Manzini region. The mean age was 33.3 years (standard deviation 7.0), and 33% (n = 7,714) were first-time screens. The prevalence of a positive VIA was 2.6% (95% CI: 2.2%, 3.0%): 2.8% (95% CI: 2.2%, 3.5%) in Lubombo and 2.4% (95% CI: 2.0%, 2.9%) in Manzini (p = 0.096). Screening at mission-owned (AOR 1.40; p = 0.001), NGO-owned (AOR 3.08; p<0.001) and industrial/workplace-owned health facilities (AOR 2.37; p = 0.044) were associated with increased odds of a positive VIA compared to government-owned health facilities. Compared to those aged 25–34, the odds of a positive VIA increased by 1.26 for those in the 35–44 age group (AOR 1.26; p = 0.017). Predictors with lower odds for a positive VIA test were: being on anti-retroviral therapy (ART) for 5–9 years (AOR 0.76; p = 0.004) and ≥10 years (AOR 0.66; p = 0.002) compared to <5 years; and having an undetectable viral load (AOR 0.39; p<0.001) compared to unsuppressed. Longer duration on ART and an undetectable viral load reduced the odds, while middle-aged women and screening at non-public health facilities increased the odds of a positive VIA screen.


  • Open Access

    Factors that influence-COVID-19 Vaccine Uptake and Hesitancy Among a Population in the West Department of Haiti: Implications for Enhancing Effectiveness of Immunization Programs

    by Martine Etienne-Mesubi, Babatunji Oni, Nancy Rachel Labbe-Coq, Marie Colette Alcide-Jean-Pierre, Delva Lamarre, Darwin Dorestan, Marie-Ange Bien-Aime, Venice Dorce, Cory Freivald, Cowan Angell, et al.

    Introduction The COVID-19 pandemic in Haiti led to increased challenges for a population concurrently dealing with natural and social disasters, poor quality health care, lack of clean running water, and inadequate housing. While half a million vaccines for COVID-19 were donated by the United States to the government of Haiti, less than 5% of the population agreed to be vaccinated. This resulted in thousands of unused doses that were diverted to other countries. The purpose of this study was to evaluate population characteristics related to vaccine uptake in order to inform future interventions to improve COVID-19 vaccine uptake as well as inform strategies to safeguard against future global health security threats. Methods This was a mixed-methods, cross-sectional study conducted in the West Department of Haiti within peri-urban communes. Survey participants consisted of adults of this setting responding to an electronic survey between June – Sept 2022. The survey assessed demographic information, household characteristics, religious beliefs, past vaccine use, and current COVID-19 vaccine status. Multivariate regression modeling was conducted to assess predictors of vaccine hesitancy. Qualitative focus group discussions were conducted among community leaders and health professionals to provide additional, community-level context on perceptions of the COVID-19 pandemic and vaccines. Results A total of 1,923 respondents completed the survey; of which a majority were male (52.7%), were between the age of 18-35 (58.5%), had a medical visit with the last year (63.0%) and received the COVID-19 vaccine (46.1%). Compared to those who had been COVID-19 vaccinated, participants who had not been vaccinated were more likely to be male (57.7% vs 46.8%, p<.0001), have classical education (30.5% vs 16.6%, p<.001), unemployed (20.3% vs 7.3%, p<.0001) and had a medical visit 3 or more years ago (30.2% vs 11.2%, p<.0001). Unvaccinated COVID-19 participants were also more likely to have never received any other vaccine (36.1% vs22.5%, p<.0001), have a religious leader speak out against the vaccine (20.0% vs 13.1%, p<.0001), not believe in the effectiveness of the vaccine (51.2% vs 9.1%, p<.0001) and did not trust the healthcare worker administering the vaccine (35.2% vs 3.8%, pConclusion These results show that targeted interventions to religious leaders and health care workers on how to engage with the community and share clearer messages around the COVID-19 vaccination may result in increased vaccine uptake. Results also shed light on how activities surrounding vaccinations can be tailored to meet client needs addressing the misinformation encountered to achieve greater health impact thereby safeguarding the population against future global health security threats.

  • Open Access

    Predictors of COVID-19 Vaccine Hesitancy in North-Central Nigeria

    by Ayodotun Olutola, Ibrahim Bola Gobir, Deus Bazira, Samson Agboola, Fatimah Ohunene Sanni, Azeez Akanbi Bello, Havilah Onyinyechi Nnadozie, Aisha Adamu, Fatima Bello, Suzzy Angmun Otubo, et al.

    COVID-19 vaccine hesitancy has emerged as a major challenge to global efforts to control the pandemic, particularly in Nigeria, where hesitancy to other effective vaccines such as polio and measles has been widely reported. Several individual, societal, and structural factors contribute to this behaviour and prevent the effectiveness of COVID-19 prevention efforts. Objectives This study sought to assess the factors associated with COVID-19 vaccine hesitancy in the six states of north-central Nigeria. Methods A population-based cross-sectional online survey was conducted among residents using a semi-structured questionnaire adapted from the WHO SAGE vaccine hesitancy scale and distributed via social media networks over 8-weeks. Results A total of 1,999 responses were received, of which 570 were set aside comprising 512 respondents that resided outside the study area, 12 respondents that reported no knowledge of the COVID-19 vaccine, and 46 entries with missing data. Of 1,429 included in the analysis, 1,008 (70.5%) were willing to be vaccinated and/or already vaccinated and 421 (29.5%) were unwilling to receive the COVID-19 vaccine. Post-secondary education (AOR: 0.51, 0.37-0.69), household income above the minimum wage of 30,000 Naira per month (AOR: 0.68, 0.50-0.94) and people of the Islamic faith (AOR: 0.69, 0.53-0.90) were found to be associated with lower levels of hesitancy. The dominant reasons for hesitancy were concerns about side effects (37.5%), doubt about the existence of COVID-19 (11.0%), and the perception of time required to receive the vaccine (9.6%). Hesitant respondents relied on health workers (33.0%) and social media (23.3%) as their trusted sources of health information, and less than a third (31.4%) followed the advice of their religious and community leaders. Conclusion All three factors of confidence, complacency and convenience influenced hesitancy in our study. Socioeconomic factors are major drivers of hesitancy. Therefore, hesitancy is as much a social issue as health and requires a multisectoral approach to educating communities and building trust in health and social institutions.

  • Open Access

    Cervical Cancer Screening Outcomes for HIV-positive Women in the Lubombo and Manzini regions of Eswatini – Prevalence and Predictors of a Positive Visual Inspection with Acetic Acid (VIA) Screen

    by Rufaro Mapaona, Victor Williams, Normusa Musarapasi, Sharon Kibwana, Thokozani Maseko, Rhinos Chekenyere, Sidumo Gumbo, Phetsile Mdluli, Hugben Byarugaba, Dileepa Galagedera, et al.

    This study aimed to describe the prevalence and predictors of a positive VIA (visual inspection with acetic acid) cervical cancer screening test in women living with human immunodeficiency virus (HIV). We retrospectively analysed data from women aged ≥15 who accessed VIA screening from health facilities in the Lubombo and Manzini regions of Eswatini. Sociodemographic and clinical data from October 2020 to June 2023 were extracted from the client management information system. VIA screening outcome was categorised into negative, positive, or suspicious. A logistic regression model estimated the adjusted odds ratio (AOR) of the predictors of a positive VIA screen at p<0.05 with 95% confidence intervals. Of 23,657 participants, 60.8% (n=14,397) were from the Manzini region. The mean age was 33.3 years (standard deviation 7.0), and 33% (n=7,714) were first-time screens. The prevalence of a positive VIA was 2.6% (95% CI: 2.2%, 3.0%): 2.8% (95% CI: 2.2%, 3.5%) in Lubombo and 2.4% (95% CI: 2.0%, 2.9%) in Manzini (p=0.096). Screening at mission-owned (OR 1.40; p=0.001), NGO-owned (OR 3.08; p<0.001) and industrial/workplace-owned health facilities (OR 2.37; p=0.044) were associated with positive test results compared to government-owned health facilities, and being within the 35–44 age group (OR 1.26; p=0.017) compared to 25-34 years age group was a positive predictor of a positive VIA screen. Negative predictors of positive VIA test were: being on anti-retroviral therapy (ART) for 5-9 years (OR 0.76; p=0.004) and ≥10 years (OR 0.66; p=0.002) compared to <5 years; and having an undetectable viral load (OR 0.39; p<0.001) compared to unsuppressed. Longer duration on ART and an undetectable viral load reduced the odds, while middle-aged women and screening at non-public health facilities increased the odds of a positive VIA screen.